Atara Biotherapeutics Inc
NASDAQ:ATRA
Income Statement
Earnings Waterfall
Atara Biotherapeutics Inc
Revenue
|
8.6m
USD
|
Cost of Revenue
|
-8.9m
USD
|
Gross Profit
|
-313k
USD
|
Operating Expenses
|
-269m
USD
|
Operating Income
|
-269.3m
USD
|
Other Expenses
|
-6.9m
USD
|
Net Income
|
-276.1m
USD
|
Income Statement
Atara Biotherapeutics Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
7
+109%
|
13
+72%
|
20
+59%
|
24
+18%
|
72
+198%
|
71
-1%
|
64
-10%
|
57
-10%
|
7
-88%
|
5
-34%
|
9
+88%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(3)
|
(6)
|
(9)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
(1)
N/A
|
(1)
-52%
|
(0)
+78%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(12)
|
(18)
|
(28)
|
(30)
|
(41)
|
(47)
|
(58)
|
(66)
|
(71)
|
(84)
|
(81)
|
(90)
|
(99)
|
(104)
|
(122)
|
(138)
|
(163)
|
(191)
|
(237)
|
(263)
|
(285)
|
(298)
|
(296)
|
(303)
|
(305)
|
(307)
|
(309)
|
(316)
|
(326)
|
(342)
|
(361)
|
(375)
|
(370)
|
(363)
|
(338)
|
(319)
|
(304)
|
(290)
|
(269)
|
|
Selling, General & Administrative |
(5)
|
(7)
|
(13)
|
(12)
|
(14)
|
(17)
|
(17)
|
(19)
|
(22)
|
(25)
|
(25)
|
(28)
|
(31)
|
(35)
|
(40)
|
(46)
|
(55)
|
(61)
|
(70)
|
(75)
|
(79)
|
(81)
|
(80)
|
(77)
|
(71)
|
(66)
|
(64)
|
(65)
|
(68)
|
(73)
|
(79)
|
(82)
|
(81)
|
(77)
|
(68)
|
(61)
|
(56)
|
(52)
|
(50)
|
|
Research & Development |
(6)
|
(10)
|
(15)
|
(18)
|
(27)
|
(30)
|
(42)
|
(47)
|
(49)
|
(59)
|
(57)
|
(63)
|
(68)
|
(70)
|
(81)
|
(92)
|
(107)
|
(130)
|
(167)
|
(188)
|
(207)
|
(217)
|
(216)
|
(225)
|
(234)
|
(241)
|
(245)
|
(251)
|
(258)
|
(268)
|
(282)
|
(293)
|
(289)
|
(286)
|
(270)
|
(257)
|
(248)
|
(238)
|
(219)
|
|
Operating Income |
(12)
N/A
|
(18)
-51%
|
(28)
-60%
|
(30)
-8%
|
(41)
-35%
|
(47)
-15%
|
(58)
-24%
|
(66)
-13%
|
(71)
-7%
|
(84)
-19%
|
(81)
+4%
|
(90)
-11%
|
(99)
-9%
|
(104)
-6%
|
(122)
-16%
|
(138)
-13%
|
(163)
-18%
|
(191)
-18%
|
(237)
-24%
|
(263)
-11%
|
(285)
-9%
|
(298)
-4%
|
(296)
+1%
|
(303)
-2%
|
(305)
-1%
|
(307)
-1%
|
(309)
-1%
|
(313)
-1%
|
(319)
-2%
|
(329)
-3%
|
(340)
-4%
|
(350)
-3%
|
(299)
+15%
|
(292)
+2%
|
(275)
+6%
|
(261)
+5%
|
(301)
-15%
|
(291)
+3%
|
(269)
+8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
5
|
6
|
7
|
6
|
5
|
5
|
4
|
4
|
3
|
2
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
4
|
5
|
5
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
(6)
|
(6)
|
(0)
|
(7)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
50
|
50
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
49
|
(3)
|
(4)
|
(0)
|
|
Pre-Tax Income |
(12)
N/A
|
(18)
-51%
|
(28)
-60%
|
(30)
-7%
|
(41)
-35%
|
(47)
-15%
|
(57)
-23%
|
(65)
-13%
|
(69)
-6%
|
(82)
-20%
|
(79)
+4%
|
(88)
-12%
|
(97)
-10%
|
(102)
-6%
|
(120)
-17%
|
(135)
-13%
|
(159)
-17%
|
(186)
-17%
|
(231)
-24%
|
(256)
-11%
|
(279)
-9%
|
(293)
-5%
|
(291)
+1%
|
(298)
-2%
|
(301)
-1%
|
(304)
-1%
|
(307)
-1%
|
(311)
-2%
|
(318)
-2%
|
(328)
-3%
|
(340)
-4%
|
(350)
-3%
|
(248)
+29%
|
(247)
+0%
|
(228)
+8%
|
(215)
+6%
|
(305)
-42%
|
(290)
+5%
|
(276)
+5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
Income from Continuing Operations |
(12)
|
(17)
|
(28)
|
(30)
|
(41)
|
(47)
|
(57)
|
(65)
|
(69)
|
(82)
|
(79)
|
(88)
|
(97)
|
(102)
|
(119)
|
(135)
|
(159)
|
(186)
|
(231)
|
(256)
|
(279)
|
(293)
|
(291)
|
(298)
|
(301)
|
(304)
|
(307)
|
(311)
|
(318)
|
(328)
|
(340)
|
(350)
|
(248)
|
(247)
|
(228)
|
(215)
|
(305)
|
(290)
|
(276)
|
|
Net Income (Common) |
(12)
N/A
|
(17)
-51%
|
(28)
-60%
|
(30)
-8%
|
(41)
-35%
|
(47)
-15%
|
(57)
-23%
|
(65)
-13%
|
(69)
-6%
|
(82)
-20%
|
(79)
+4%
|
(88)
-11%
|
(97)
-10%
|
(102)
-6%
|
(119)
-17%
|
(135)
-13%
|
(159)
-17%
|
(186)
-17%
|
(231)
-24%
|
(256)
-11%
|
(279)
-9%
|
(293)
-5%
|
(291)
+1%
|
(298)
-2%
|
(301)
-1%
|
(304)
-1%
|
(307)
-1%
|
(311)
-2%
|
(318)
-2%
|
(328)
-3%
|
(340)
-4%
|
(350)
-3%
|
(248)
+29%
|
(247)
+0%
|
(228)
+8%
|
(215)
+6%
|
(305)
-42%
|
(290)
+5%
|
(276)
+5%
|
|
EPS (Diluted) |
-0.59
N/A
|
-0.88
-49%
|
-5.62
-539%
|
-1.37
+76%
|
-1.67
-22%
|
-1.68
-1%
|
-2.24
-33%
|
-2.26
-1%
|
-2.39
-6%
|
-2.84
-19%
|
-2.75
+3%
|
-3.05
-11%
|
-3.3
-8%
|
-3.36
-2%
|
-4
-19%
|
-3.41
+15%
|
-3.57
-5%
|
-4.09
-15%
|
-5.27
-29%
|
-5.54
-5%
|
-6
-8%
|
-5.32
+11%
|
-5.67
-7%
|
-4.87
+14%
|
-4.43
+9%
|
-3.74
+16%
|
-4.15
-11%
|
-3.4
+18%
|
-3.44
-1%
|
-3.5
-2%
|
-3.63
-4%
|
-3.47
+4%
|
-2.43
+30%
|
-2.41
+1%
|
-2.24
+7%
|
-2.08
+7%
|
-2.89
-39%
|
-2.72
+6%
|
-2.61
+4%
|